Drug advisory committee needs more time on Johnson and Johnson vaccine decision

The Center for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practice (ACIP) decline to vote in a special meeting April 14 on whether to lift a federal pause on using the Johnson and Johnson COVID-19 vaccine. According to a report in The New York Times, the pause could continue for a week to 10 days after ACIP decided it needed more time to assess the possible link between the single-dose vaccine.
Read more...

;